Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors

NCT00115128 · clinicaltrials.gov ↗

COMPLETED

Status

309

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal PBPC Donors

Interventions

DRUG: filgrastim

Sponsor

Amgen